Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04482309 |
Title | A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors (DPT02) |
Acronym | DPT02 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | AstraZeneca |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | POL | NLD | ITA | GBR | ESP | CZE | CAN | BRA | BEL | AUS |